Nader is the reason the stock is acting as it is, which is not positive. He has no idea how to manage expectations, gets too emotional where emotion has NO business being, and doesn't give a good interview. And yet, if/when Leronlimab is approved and the share price goes up, most of you will hail him as a hero. Even a broken clock...you know the rest.